<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00702611</url>
  </required_header>
  <id_info>
    <org_study_id>Ada-UC-07-102</org_study_id>
    <nct_id>NCT00702611</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis</brief_title>
  <acronym>ATICCA</acronym>
  <official_title>An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone Plus Adacolumn® GMA Apheresis vs Prednisone Alone in the Treatment of Patients With Mild or Moderately Active Steroid Dependent Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of the addition of GMA apheresis to
      steroid conventional treatment for achieving and maintaining remission in Active steroid
      dependant Ulcerative Colitis patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter randomized controlled trial which will compare the efficacy and safety
      of Adacolumn GMA apheresis plus oral steroids vs steroids alone in a strictly selected
      population of moderate to severe active steroid dependant Ulcerative Colitis patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of enrollment
  </why_stopped>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients in steroid free clinical remission defined by Mayo Score less or equal to 2 with no individual subscore &gt;1 at week 24</measure>
    <time_frame>week 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Steroid free remission (assessed by Mayo score)</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response at week 12 and 24 (defined by a decrease in Mayo Score &gt; or = to 3 points</measure>
    <time_frame>week 12 and week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Phase reactants change at all lab analysis</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue therapy requirements (new courses of steroids, cyclosporine, infliximab, or surgery) during study period</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to relapse</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>· Clinical response according to the activity indexes Truelove &amp; Witts, Powell Tuc, Rachmiliewitz (Clinical Activity Index), Lichtiger (Modified Truelove &amp; Witts Severity Index), Walmsley (Simple Clinical Colitis Index</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical remission and response at weeks 12 and 24 analysed according to concomitant use of immunosupressants</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Seven apheresis treatments over seven consecutive weeks (1/week) in conjunction with a starting dose of 40mg of oral prednisone per day at Week 00 for two weeks which will be tapered down to zero 5 mg/week within nine weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with starting dose of 40mg of oral prednisone per day at Week 00 for two weeks and tapered down to zero 5 mg/week within nine weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Granulocyte Monocyte Apheresis (GMA-Apheresis)</intervention_name>
    <description>GMA Apheresis will be performed in a once per week during seven weeks only in experimental arm. Each apheresis will last 60 minutes at a blood flow rate of 30 ml/min.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 75 years old

          -  Active ulcerative colitis with documented clinical symptoms and endoscopic findings

          -  Active disease defined as DAI (Mayo score) ≥ 4 and ≤10 with at least 1 point in
             flexible sigmoidoscopy

          -  Steroid dependency as defined by:

        A. Inability to withdraw corticosteroids within three months of starting treatment, without
        recurrent active disease

        B. appearance of relapse within 3 months after withdrawal of corticosteroids

          -  Colonic involvement with ulcerative colitis beyond 15cm of the anal verge

          -  Stable doses:A. Aminosalicylates for the last 4 weeks B. Prednisolone or equivalent
             dose ≤ 20 mg/day for the last 2 weeks C. Azathioprine or 6-mercaptopurine at stable
             dose for the last 12 weeks

          -  Signed informed consent form

          -  Agree to participate in the required follow-up visits

          -  Able to complete the diary

        Exclusion Criteria:

          -  Febrile (&gt; 38ºC)

          -  Evidence of toxic megacolon

          -  Anticipated need for surgery within 24 weeks

          -  Known obstructive diseases of the gastrointestinal system

          -  Proctocolectomy, total colectomy, ileostomy, stoma or ileal pouch-anal anastomosis

          -  A history of allergic reaction to heparin or heparin-induced thrombocytopenia

          -  A history of hypersensitivity reaction associated with an apheresis procedure or
             intolerance of apheresis procedures

          -  Requires a central venous access catheter for the apheresis treatments

          -  Known infection with enteric pathogens, pathogenic ova or parasites, C. difficile
             toxin or CMV

          -  Hypotension (systolic blood pressure &lt;80 mmHg and/or diastolic blood pressure &lt;50
             mmHg) at screening visit only

          -  Uncontrolled hypertension (systolic blood pressure &gt;180 mmHg or diastolic blood
             pressure &gt;120 mmHg) despite medical therapy

          -  A history of myocardial infarction or unstable angina within the past 6 months

          -  A history of coronary artery bypass grafting surgery or angioplasty within the past 6
             months

          -  Prosthetic heart valve, pacemaker or other permanent implant

          -  Severe cardiovascular or peripheral vascular disease, severe renal disease

          -  Liver disease defined as levels of SGOT [AST], SGPT [ALT] or alkaline phosphatase
             &gt;2.5x the upper limit of the normal range for the laboratory performing test

          -  History of cirrhosis

          -  Known bleeding disorder (PT or PTT&gt;1.5x the upper limit of the normal range for the
             laboratory performing the test), or concomitant anticoagulant therapy for purposes
             other than apheresis treatment

          -  Prior history suggestive of a hypercoagulable disorder, including 1 or more episodes
             of pulmonary embolism or deep vein thrombosis

          -  Known infection with Hepatitis B or C, or HIV

          -  Abnormal hematology parameters defined as severe anemia with hemoglobin &lt;8.5g/dL,
             white blood cell count of &lt;3,500/μl and a granulocyte count &lt; 2,000/μl

          -  Fibrinogen level &gt;700mg/dL

          -  Major surgery within the past 6 months

          -  Infection:Active infections less than 4 weeks from successful completion of antibiotic
             treatment for routine bacterial infectionFebrile viral infection within 4 weeks of
             entry into the clinical investigationLess than 12 weeks from conclusion of therapy for
             systemic fungal infections

          -  Malignancy within the past 2 years other than surgically cured skin carcinoma or
             cervical dysplasia (CIN I-II)

          -  History of dysplasia or carcinoma of the colon or lack of a complete colonoscopy in
             the last 12 months in patients with longstanding UC (&gt; 10 años)

          -  Current drug or alcohol abuse

          -  Pregnant, lactating or planning to become pregnant during the course of the clinical
             investigation

          -  Used within the last 30 days an investigational drug, biologic or device or 5
             half-lifes, if known, for any investigational drug or biologic

          -  Received cyclosporine or tacrolimus within the last 8 weeks

          -  Received infliximab within the last 8 weeks

          -  Fulminant ulcerative colitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian Panes, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic i Provincial Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joaquín Hinojosa, Ph D</last_name>
    <role>Study Chair</role>
    <affiliation>Geteccu President</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Ginard, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Son Dureta Palma de Mallorca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugeni Domenech, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germans Trias i Pujol Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raul Lafuente, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Otsuka Pharmaceutical S.A.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Magro, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital San Joao, Oporto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vito Annesse, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Casa Sollievo de la Sofferenza, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katolische Kliniken Ruhrhalbinsel</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Markus-Krankenhaus</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico di Bari</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Belluno</name>
      <address>
        <city>Belluno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L'Azienda Unità Sanitaria Locale di Forlì</name>
      <address>
        <city>Forli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Policlinico S. Donato</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico di Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Tor Vergata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa Sollievo della Sofferenza, Istituto di Ricovero e Cura a Carattere Scientifico, Opera di San Pio da Pietrelcina</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital da Universidade de Coimbra</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-075</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Portuges Oncologia Lisboa Francisco Gentil</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral Santo Antonio</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Sao Joao</name>
      <address>
        <city>Porto</city>
        <zip>4200-319</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Sao Bernardo</name>
      <address>
        <city>Setubal</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Teotonio</name>
      <address>
        <city>Viseu</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hspitalario Universitario Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruña</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <state>Andalucía</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mutua de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Galdakano</name>
      <address>
        <city>Galdakao</city>
        <state>Bilbao</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Comunidad Balear</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario Juan Canalejo</name>
      <address>
        <city>A Coruña</city>
        <state>Galicia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia</name>
      <address>
        <city>San Sebastian</city>
        <state>Guipuzcoa</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Puerto de Sagunto</name>
      <address>
        <city>Sagunto</city>
        <state>Valencia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic i Provincial</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Josep Trueta</name>
      <address>
        <city>Girona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Insular de Las Palmas</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Leon</name>
      <address>
        <city>Leon</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Fundación de Alcorcón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clínico de San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Costa del Sol</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Manises</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital do Meixoeiro</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.geteccu.org/</url>
    <description>Official web page of the GETECCU group</description>
  </link>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2008</study_first_submitted>
  <study_first_submitted_qc>June 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2008</study_first_posted>
  <last_update_submitted>September 4, 2015</last_update_submitted>
  <last_update_submitted_qc>September 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ulcerative Colitis</keyword>
  <keyword>Inflammatory Bowel disease</keyword>
  <keyword>Steroid dependent</keyword>
  <keyword>Adacolumn</keyword>
  <keyword>Apheresis</keyword>
  <keyword>Granulocyte Monocyte apheresis</keyword>
  <keyword>GMA apheresis</keyword>
  <keyword>Granulocytapheresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

